The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease – A systematic literature review by a European panel of experts
Dominique P. Germain(Assistance Publique – Hôpitaux de Paris), Marco Spada(University of Turin), Derralynn Hughes(Royal Free London NHS Foundation Trust), Michael Arad(Tel Aviv University), Bruno Falissard(Inserm), Christoph Wanner(Universitätsklinikum Würzburg), Frank Weidemann(Katharinenhospital), Max J. Hilz(Friedrich-Alexander-Universität Erlangen-Nürnberg), Alberto Ortíz(Universidad Pontificia de Salamanca), Ulla Feldt‐Rasmussen(Copenhagen University Hospital), Alessandro P. Burlina(Santa Maria Nuova Hospital), Perry Elliott(St Bartholomew's Hospital)
Cited by 106
Related Papers
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k